http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005038115-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 |
filingDate | 2004-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_434c36a1ab0ef1724d703cc6ea183f07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f98abc4351471107580d41048fc60648 |
publicationDate | 2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2005038115-A1 |
titleOfInvention | Helianthrone derivatives as anti-cancer agents |
abstract | Hypericin and helianthrone derivatives of general formula (I) n n nwherein the dotted line between positions 11 and 12 represent an optional C11-C12 bond; R is independently selected from the group consisting of hydroxy, C 1 -C 10 alkoxy, NH—C 1 -C 10 alkyl, and NH-hydroxy(C 1 -C 10 )alkyl; R′ is independently selected from the group consisting of hydroxy and C 1 -C 10 alkoxy; R″ is independently selected from the group consisting of hydrogen, hydroxy, C 1 -C 10 alkoxy, NH—C 1 -C 10 alkyl, and NH-hydroxy(C 1 -C 10 )alkyl; and R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are independently selected from the group consisting of hydrogen, hydroxy, chloro, bromo, C 1 -C 10 alkyl, C 1 -C 10 alkoxy, and C 1 -C 10 alkoxycarbonyl, provided that R″ is not hydrogen when there is a C11-C12 bond and when there is a C11-C12 bond and both R′ are hydroxy, both R″ groups are not hydroxy. These compounds and pharmaceutical compositions containing them as active agents are useful as inhibitors of angiogenesis and can be used to prevent formation of metastases and restenosis and for the treatment of angiogenesis-associated ophthalmologic disorders. In addition, the helianthrone derivatives of formula (I) can be used for the treatment of tumors in the absence of light irradiation. |
priorityDate | 2000-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.